U.S. markets closed

THC Biomed Intl Ltd. (THC.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.0950+0.0050 (+5.56%)
At close: 3:51PM EST

THC Biomed Intl Ltd.

1340 St. Paul Street
Kelowna, BC V1Y 2E1
Canada

http://thcbiomed.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees45

Key Executives

NameTitlePayExercisedYear Born
Mr. John MillerPres, CEO & Director66.75kN/AN/A
Jung Chun HeeCo-Founder, CFO & Director66.66kN/AN/A
Mr. Damien ReynoldsChief Capital Markets OfficerN/AN/AN/A
Ms. Dianne Marie SzigetyCorp. Sec.N/AN/A1954
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. The company conducts research and development of products and services related to the medical cannabis industry. It also offers cannabis beverage under the THC KISS brand name, as well as pure cannabis sticks. The company was founded in 2012 and is headquartered in Kelowna, Canada.

Corporate Governance

THC Biomed Intl Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.